Market News

The Ebola virus still sweeping across West Africa has already taken at least 1,350 lives and is costing the affected countries dearly. But on Wall Street, biotech companies such as Tekmira Pharmaceuticals Corp. (TSE:TKM)...

Two years ago, M&T Bank Corp. announced a $3.7 billion deal to buy Hudson City Bancorp. But regulators at the Federal Reserve have held up the deal ever since, a move that is widely seen as having helped chill the merger...

This year, Keurig entered into some game changing deals and partnerships with companies having strong brand appeal and huge customer base such as Coca-Cola, the Nestle U.S. division, Subway and J.M. Smucker Co. Although ...

British drugmaker GlaxoSmithKline's (LON:GSK) (NYSE:GSK) experimental Ebola vaccine was approved for testing on human beings, even as the death toll from the deadly virus continues to increase. Bloomberg reported that th...

At Holdings Channel, we have reviewed 3,729 13F filings for the 06/30/2014 reporting period, and looked at the various S&P 500 components held by each of these reporting hedge funds and other 13F filers. For each compone...

Blackstone Group, weeks away from the start of a new "big bet" hedge fund, is close to landing its first traders who will scour the world for concentrated investments, people familiar with the matter said.

In afternoon trading on Thursday, Financial stocks are the worst performing sector, showing a 0.2% loss. Within that group, Prudential Financial (NYSE: PRU) and Legg Mason (NYSE: LM) are two large stocks that are lagging...

In afternoon trading on Thursday, Utilities stocks are the best performing sector, up 0.6%. Within that group, Wisconsin Energy (NYSE: WEC) and DTE Energy (NYSE: DTE) are two of the day's stand-outs, showing a gain of 1....

Apple may be bigger than ever, but it hasn't lost its sense of mystery.

The US economy grew at 4.2 percent QoQ in Q2 2014. This was better than expected and indicates that it will be able to handle not just the end of QE, but a rate hike in mid 2015.

A deeper look at fiscal first-quarter earnings shows a meaningful recovery in the economy still has a ways to go

ED seizes N.K. Proteins assets in Mumbai, Noida, Ahmedabad and Palanpur

Brokers fined for fraudulent trading, violating broker norms

Although we don't expect BNY Mellon to incur any direct financial penalties from the ongoing debt row, the bank's loss of the Argentine government as a client is bound to have repercussions for its operations in the regi...

The WICED sense kit promises to shorten the time between early ideas and end products by providing innovators of all sizes with a cost-effective platform that minimizes set-up time and enables rapid demonstrations of IoT...

Given the present conditions, Deere decided to cut down production to bring it in line with current market demand. Deere also cut down its revenue guidance for the fiscal year 2014 citing the weak farm equipment demand. ...

When hedge fund manager "titans" think alike, investors are wise to pay attention. At Holdings Channel, we have reviewed 3,729 13F filings for the 06/30/2014 reporting period, and noticed that Motorola Solutions (NYSE: M...

Going forward, the company expects to grow its net hydrocarbon production at 5-7% CAGR in the long run, with sales volume from the Wattenberg field expected to grow at 20% CAGR until at least 2018. We currently forecast ...

At Holdings Channel, we have reviewed 3,729 13F filings for the 06/30/2014 reporting period, and looked at the various S&P 500 components held by each of these reporting hedge funds and other 13F filers. For each compone...

The carrier's operating revenues grew 5.3% y-o-y to about RMB 166 billion ($27 billion) on account of increasing 3G service revenues and consistent growth in fixed broadband. Revenues from 3G service increased as the car...

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to ...

British drugmaker GlaxoSmithKline's (LON:GSK) (NYSE:GSK) experimental Ebola vaccine was approved for testing on human beings, even as the death toll from the deadly virus continues to increase. Bloomberg reported that th...